Key2Brain
Pre-clinicalJoint research to develop CNS-targeted siRNAs using Key2Brain’s TfR-targeted BBB shuttle, with an option for a global exclusive license to a CNS disease target
Founded
2018
Focus
AntibodiesBiologics
About
Joint research to develop CNS-targeted siRNAs using Key2Brain’s TfR-targeted BBB shuttle, with an option for a global exclusive license to a CNS disease target
Company Info
TypePrivate
Founded2018
LocationStockholm, Sweden
StagePre-clinical
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile